Yield of diffusion-weighted MRI for detection of potentially relevant findings in stroke patients

Neurology

Volumn 54, Issue 8, 2000, Pages 1562-1567

  Albers, Gregory W ^a   Lansberg, M G ^a   Norbash, A M ^b   Tong, D C ^a   O'Brien, M W ^a   Woolfenden, A R ^c   Marks, M P ^a   Moseley, M E ^a  

^a Stanford Medicine Children s Health   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Building B ^*

Author keywords

Cerebral ischemia; Clinical relevance; Diffusion weighted MRI; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; HEALTH CARE COST; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STROKE;

EID: 0034007960     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.8.1562     Document Type: Article

References (29)

1. Gonzalez RG, Schaefer PW, Buonanno FS, et al. Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 1999;210: 155-162.
2. Marks MP, de Crespigny A, Lentz D, et al. Acute and chronic stroke: navigated spin-echo diffusion-weighted MRI. Radiology 1996;199:403-408.
3. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab 1996;16:53-59.
4. Lovblad KO, Laubach HJ, Baird AE, et al. Clinical experience with diffusion-weighted MR in patients with acute stroke. AJNR Am J Neuroradiol 1998;19:1061-1066.
5. Sorensen AG, Buonanno FS, Gonzalez RG, et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MRI. Radiology 1996;199:391-401.
6. Fisher M, Albers GW. Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke. Neurology 1999;52:1750-1756.
7. Lutsep HL, Albers GW, DeCrespigny A, et al. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 1997;41:574-580.
8. Read SJ, Jackson GD, Abbott DF, et al. Experience with diffusion-weighted imaging in an acute stroke unit. Cerebrovasc Dis 1998;8:135-143.
9. van Everdingen KJ, van der Grond J, Kappelle LJ, et al. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke 1998;29:1783-1790.
10. Powers WJ, Zivin J. Magnetic resonance imaging in acute stroke: not ready for prime time. Neurology 1998;50:842-843.
11. Zivin J. Diffusion-weighted MRI for diagnosis and treatment of ischemic stroke. Ann Neurol 1997;41:567-568.
12. Prichard JW, Grossman RI. New reasons for early use of MRI in stroke. Neurology 1999;52:1733-1736.
13. Schlaug G, Siewert B, Benfield A, et al. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology 1997;49:113-119.
14. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998;18:583-609.
15. Schaefer PW, Buonanno FS, Gonzalez RG, et al. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997;28: 1082-1085.
16. Corvol JC, Oppenheim C, Manai R, et al. Diffusion-weighted magnetic resonance imaging in a patient of cerebral venous thrombosis. Stroke 1998;29:2649-2652.
17. Schwartz RB, Mulkern RV, Gudbjartsson H, et al. Diffusion-weighted MRI in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol 1998;19:859-862.
18. Ay H, Buonanno F, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998;51:1369-1376.
19. Woolfenden AR, O'Brien M, Schwartzberg RE, et al. Diffusion-weighted MRI in transient global amnesia precipitated by cerebral angiography. Stroke 1997;28:2311-2314.
20. The Warfarin-Aspirin Symptomatic Intracranial Disease Study Group. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995;45:1488-1493.
21. Marks MP, Marcellus M, Norbash AM, et al. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999;30:1065-1069.
22. Woolfenden AR, Tong C, Norbash AM, et al. Basilar artery stenosis: clinical and neuroradiologic features. J Stroke Cerebrovasc Dis 2000 (in press).
23. The Warfarin-Aspirin Symptomatic Intracranial Disease Study Group. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 1998;29:1389-1392.
24. Mead GE, Wardlaw JM, Lewis SC, McDowall M, Dennis MS. Can simple clinical features be used to identify patients with severe carotid stenosis on Doppler ultrasound? J Neurol Neurosurg Psychiatry 1999;66:16-19.
25. Boiten J, Lodder J. Lacunar infarcts: pathogenesis and validity of the clinical syndromes. Stroke 1991;22:1374-1378.
26. The European Carotid Surgery Trial Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379-1387.
27. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998;339:1415-1425.
28. Schellinger PD, Jansen O, Fiebach JB, Hacke W, Sartor K. A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke 1999;30:765-768.
29. Patel MR, Edelman R, Warach S. Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging. Stroke 1996;27:2321-2324.